SEC Filing Analysis: CVRx, Inc. (CVRX)

Executive Summary

• Trading Significance: Low
• Key Takeaway: Johnson & Johnson, a 10% owner, executed a minor sale of CVRx stock worth approximately $27,000, representing less than 0.1% of its total position.
• Market Impact: Neutral. The transaction is too small to imply a change in the insider's strategic outlook on CVRx.

Company Information

Field	Value
Company	CVRx, Inc.
Ticker Symbol	CVRX
CIK	0001235912
Industry	Surgical & Medical Instruments & Apparatus

Insider Information

Field	Value
Name	JOHNSON & JOHNSON
CIK	0000200406
Title/Position	N/A
Relationship	Ten Percent Owner

Transaction Details

Field	Value
Form Type	4
Transaction Date	2025-11-21 to 2025-11-24
Transaction Code	S (Sale)
Security Type	Common Stock
Shares Involved	2,700
Price Per Share	~$10.05 (Weighted Average)
Total Value	$27,132
Shares Owned After	4,047,198
Ownership Type	Indirect (via Johnson & Johnson Innovation - JJDC, Inc.)

Financial Impact Assessment

Transaction Materiality

Note: The provided market data ($472.05B market cap) pertains to the reporting owner, Johnson & Johnson (JNJ), not the issuer, CVRx, Inc. (CVRX). The following percentages illustrate the transaction's immateriality to JNJ.

Metric	Value
Transaction Value	$27,132
% of JNJ Market Cap	<0.00001%
Shares Transacted	2,700
% of JNJ Shares Outstanding	<0.00012%
Sale as % of Insider's CVRX Holdings	~0.067%
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: The transaction value is negligible for a mega-cap company like Johnson & Johnson. The key context is not the impact on JNJ, but the signal it sends regarding its investment in CVRX.
• Ownership Concentration: Johnson & Johnson, through its subsidiary, remains a significant institutional owner with over 4 million shares after the sale. This minor disposition does not materially alter its substantial ownership stake.
• Transaction Significance: The sale represents a tiny fraction (~0.067%) of J&J's total holdings in CVRX. Such a small trim is often related to routine portfolio rebalancing or liquidity needs and is not considered a significant strategic move.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: The sale is de minimis in both absolute dollar value and as a percentage of the insider's holdings. It does not provide a meaningful signal about the insider's confidence in CVRx's future prospects.

Volume & Sentiment

• Expected Volume Impact: Negligible. The transaction size is too small to have a noticeable effect on trading volume.
• Sentiment Indicator: Neutral. While insider sales can be bearish, the insignificant size of this transaction neutralizes any negative sentiment.

Additional Context

Transaction Notes

• Structure: The filing reports two separate sale transactions on November 21 (500 shares @ $10.00) and November 24 (2,200 shares at a weighted average price of $10.06).
• Ownership: The shares are held indirectly by Johnson & Johnson through its wholly-owned subsidiary, Johnson & Johnson Innovation - JJDC, Inc., as noted in the filing's footnotes.